Cannabis Law Report

JANUARY 9, 2019

Then I saw someone with Stage 4 breast cancer end up in remission from cannabis-based therapy, someone else with skin cancer; kid after kid with seizures all being treated. The largest cause of death in South Pacific females is cervical cancer; as there is little or no access to chemotherapy or radiotherapy.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option.

Access 45

Access Patients Marijuana Medicine 45

SpeedWeed

MARCH 13, 2021

Less well-known symptoms include sleep disorders , cognitive changes, pain, anxiety, depression , and hallucinations. As a result, many PD patients now have legal access to cannabis as an alternative or complementary therapy. After analyzing the data, the researchers found that 24.5%

Patients 52

Patients Treatment Therapy Sleep 52

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Let’s find out. . Combat-Related PTSD is Slightly Different From PTSD .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

DECEMBER 7, 2021

The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients. Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Healer

MARCH 26, 2021

For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . “It We have a lot less data on the use of cannabis as a treatment for opioid use disorder,” Sulak said. .

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

CannaTech

FEBRUARY 25, 2019

Kanabo’s proprietary medical cannabis extracts focus on sleep disorders and post-traumatic stress disorder, and are specially formulated for vaporization with the medically certified VapePod vaporizer platform. Indorz : Indoor cannabis farming data solution that predicts, analyzes, and automates the grow process to maximize yield and quality.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

Cannabis Info

MARCH 2, 2019

Cannabis is being viewed as a potential treatment for epileptic seizures and large success has been witnessed so far, triggering a large movement of people and organisations who are in favour of its access and medicinal use. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Greencamp

AUGUST 16, 2018

The ECS plays an important role in managing numerous processes, ranging from sleep, mood, immune functions, metabolism, movement and pain. Our body produces internal cannabinoids called endocannabinoids, and the compounds from the cannabis plant access the ECS in a similar manner as our own endocannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Cannabis Law Report

JULY 30, 2019

Like others, Dr. Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Patient and physician are on this rocky journey together, for better or worse. . through international sources, namely Israel. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

The Cannigma

JANUARY 19, 2022

She explains how the state legislature in New York prevented her from accessing the medication she needed, as well as how difficult it was navigating the world of medical cannabis and finding a product that reliably worked for her. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca.

Patients 83

Patients Compliance Compliance Cannabis 83

The Cannigma

FEBRUARY 3, 2022

Let’s go ahead and dive right in on this one if you’re cool with it and then for the listeners, if you want to hang around afterwards, we have a segment from Americans for Safe Access here on the podcast and they share some useful insights every week so be sure to listen when we’re done. EG: All right, let’s listen to Dr. Bone. INTERVIEW].

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

StrainConnect

FEBRUARY 8, 2019

Until recently, CBD isolate was considered the best cannabis therapy option. Since CBD is the second-most researched cannabinoid and has shown refutable therapeutic evidence, creating a concentrated form to use for therapy just made sense(20). In this case, it is suggested that CBD is used for therapy versus products high in THC.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. Truffles Therapy.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51